🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSwitzerland BAG coverage — 12 month update Page 6

Switzerland BAG coverage — 12 month update

SarahChen_PharmD Mon, Feb 2, 2026 at 5:10 PM 29 replies 1,533 viewsPage 6 of 6
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Feb 5, 2026 at 11:38 AM#26

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

31 4fiona_VT, denise_HTX, raj_cambridge and 28 others
Reply Quote Save Share Report
KristenIndy
Member
623
2,678
May 2024
Indianapolis, IN
Feb 5, 2026 at 6:43 PM#27

A narrower follow-up, since the general answer is now clear:

What would you measure differently if you were starting again?

32 5amsterdam_pete, LondonLisa, mike_nyc and 29 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Feb 6, 2026 at 1:48 AM#28
DanielChem_CHI said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.

33 6ingrid_STO, pete_nash, hank_denver and 30 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Feb 6, 2026 at 8:53 AM#29
DanielChem_CHI said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.

Happy to go further on any of that.

34 7Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 31 others
Reply Quote Save Share Report
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Feb 6, 2026 at 3:58 PM#30

Closing the loop on my own question.

Follow-up — getting the denial reason in writing was the step that mattered. It named the criterion, and the criterion was a document I already had.

6 4robert_kc, dan_philly, MeganSA_TX and 3 others
Reply Quote Save Share Report
1456

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register